Regulator makes record illicit weight loss medicine seizure

Officers from the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) have made a record seizure at an illicit weight loss medicine production facility.

(c) Towfiqu Barbhuiya/Unsplash

(c) Towfiqu Barbhuiya/Unsplash

The seizure of thousands retatrutide and tirzepatide pens with a street value of over £250,000 was made at an industrial estate on the outskirts of Northampton.

Secretary of state for health and social care, Wes Streeting, said: ‘This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and illegal weight loss jabs to make a quick buck. 

‘These unregulated products, made with no regard for safety or quality, posed a major risk to unwitting customers. 

"My message is clear: don't buy weight loss medications from unregulated sources. Talk to your GP, seek NHS advice, and don't line the pockets of criminals who don't care about your health. Safe, appropriate, licensed obesity drugs can greatly benefit those in need if taken under medical supervision, and I urge people to only purchase and use them with the approval and oversight of medics and pharmacists.'

Andy Morling, head of the MHRA's CEU, said:‘Taking out the first illicit weight loss medicine manufacturing facility found in the UK is a landmark result for the MHRA and a major blow to the illegal trade. These products are untested, unauthorised, and potentially deadly. By taking this organised criminal network out of operation and stopping tens of thousands of potentially fatal products from entering circulation, we've prevented a serious risk to public health.'

Regulating right

Regulating right

By Lee Peart 30 January 2026

Thomas Reynolds, director of policy & comms at the MDU, says it is time for real reform of regulating doctors.

Pharmacists warn NHS underfunding medicines by up to 80%

By Lee Peart 29 January 2026

Pharmacists have warned of potential medicines shortages due to the NHS paying only 20% of some drugs.

The NHS 10-Year Plan: Why listening at scale matters for local government

By Lee Peart 28 January 2026

Ruth Cousens, chief executive of Thiscovery, outlines what 250,000 voices reveal about prevention, place and the future role of councils.


Popular articles by Lee Peart